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Abstract 
To maintain euglycemia in healthy organisms, hepatic glucose production is increased during fasting and decreased 
during the postprandial period. This whole process is supported by insulin levels. These responses are associated with 
the insulin signaling pathway and the reduction in the activity of key gluconeogenic enzymes, resulting in a decrease 
of hepatic glucose production. On the other hand, defects in the liver insulin signaling pathway might promote 
inadequate suppression of gluconeogenesis, leading to hyperglycemia during fasting and after meals. The hepato-
cyte nuclear factor 4, the transcription cofactor PGC1-α, and the transcription factor Foxo1 have fundamental roles in 
regulating gluconeogenesis. The loss of insulin action is associated with the production of pro-inflammatory biomol-
ecules in obesity conditions. Among the molecular mechanisms involved, we emphasize in this review the participa-
tion of TRB3 protein (a mammalian homolog of Drosophila tribbles), which is able to inhibit Akt activity and, thereby, 
maintain Foxo1 activity in the nucleus of hepatocytes, inducing hyperglycemia. In contrast, physical exercise has been 
shown as an important tool to reduce insulin resistance in the liver by reducing the inflammatory process, including 
the inhibition of TRB3 and, therefore, suppressing gluconeogenesis. The understanding of these new mechanisms by 
which physical exercise regulates glucose homeostasis has critical importance for the understanding and prevention 
of diabetes.
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Background
Diabetes mellitus type 2 (DM2) is highly prevalent in 
modern society and is closely related to obesity. Its gene-
sis is linked to insulin resistance (pre-diabetes condition) 
and there seems to be a triad of recurrent and intricate 
phenomena capable of contributing to the patient’s 
hyperglycemic condition with DM2. These are the fol-
lowing: (1) increased hepatic glucose production (via 
marked increase of glycogenolysis and gluconeogenesis 
molecules); (2) decreased insulin secretion and activity; 
and (3) reduced usage and storage of glucose in the body 
[1, 2].
The normal activity of glucagon and insulin signal-
ing pathway in the liver is important for the control of 
hepatic glucose production. On one hand, glucagon pro-
motes gluconeogenesis through two pathways: The first is 
via activating PGC-1α that will interact with FoxO1 and 
then increase the synthesis of phosphoenolpyruvate car-
boxykinase (PEPCK) and G6Pase, consequently increas-
ing the gluconeogenesis in the liver [3]. The second way 
is via increasing Inositol 1,4,5-triphosphate (IP3), which 
acts on the calcium-releasing channels of the endoplas-
mic reticulum (ER) by releasing calcium (Ca) to the cyto-
sol. In the cytosol, the Ca will act as a second messenger 
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activating the cytoplasmic calcium-sensitive kinase and 
the calcium/calmodulin dependent-protein kinase II 
(CaMKII). In turn, CaMKII will activate MAPK p38α 
that will phosphorylate FoxO1 at Ser295 and 475, as well 
as Ser246; the phosphorylated FoxO1 will then enter the 
cell nucleus and consequently bind to PGC-1α to induce 
target genes that are responsible for the transcription of 
genes responsible for glycogenolysis and gluconeogenesis 
such as G6Pase and Phosphoenolpyruvate carboxykinase 
1 (PCK1) in the liver [4–6]. On the other hand, insulin 
activation promotes a reduction in the expression and 
activity of the gluconeogenic enzymes, such as PEPCK 
and G6Pase, which results in a decreased hepatic glucose 
production [7–9]. In contrast, when hepatic insulin sign-
aling is compromised, an inadequate suppression of glu-
coneogenic pathways will ensue, which will lead to high 
levels of glucose and insulin in postprandial and fasting 
states [7, 10].
The regular practice of physical exercise is a non-
pharmacological strategy recognized and indicated for 
the prevention and treatment of diabetes. It was dem-
onstrated in a previous study that lifestyle changes, 
including the practice of regular physical exercise and 
nutritional education, had higher protective effect against 
the development of diabetes when compared to the sole 
use of metformin [11]. This scientific evidence indicates 
that exercise is indeed an important strategy in prevent-
ing insulin resistance and should be used to circumvent 
the development of diabetes.
However, it is still not clear how physical exercise pro-
motes a reduction in hyperglycemia. Furthermore, it is 
observed in the literature that most studies used skel-
etal muscle changes as their primary outcome [12–15]. 
In fact, many of the beneficial effects of physical exer-
cise occur in other tissues which might not be directly 
involved in muscle contraction. This review was con-
ducted to show how physical exercise could influence 
hepatic glucose production (with an emphasis on gluco-
neogenesis) and contribute to the maintenance of glucose 
homeostasis in a state of insulin resistance. In particu-
lar, this review elucidated the effects of physical exercise 
on TRB3 levels by minimizing its adverse effects on the 
insulin signaling pathway and the subsequent increase in 
gluconeogenesis in the liver.
Obesity and insulin resistance: the role of TRB3 
protein
The relationship between obesity and insulin resistance 
has been intensively investigated and it is known that 
many biomolecules from the adipocytes are capable of 
inducing insulin resistance through different mecha-
nisms. A recent study has shown that some types of 
fatty acids originating from the diet, especially saturated 
fatty acids, are able to bind to -and thus activate- mem-
brane proteins referred to as toll like receptor 4 (TLR4) 
[16]. TLR4 are mediators of the immunological innate 
response and their activation promotes negative conse-
quences on the insulin pathway, such as the activation of 
serine kinases [16, 17]. More specifically, the activation of 
TLR4 induces the activation of IKKβ (Ikappakinase beta) 
and JNK (c-jun N-terminal kinase), resulting in the phos-
phorylation of the insulin receptor (IR) and the insulin 
receptor substrates 1 and 2 (IRS-1/2) in a serin residue 
(instead of treonin), which leads to a decreased insulin 
signal in many tissues, including the liver [16].
TLR4 can also activate the complex called IKK/IKB/
NFKB. When active, IKKβ promotes the phosphorylation 
of IKB, culminating in the dissociation of the IKB/NFKB 
complex. Once free in the cell, NFKB is able to translo-
cate to the nucleus and promote the transcription of new 
inflammatory cytokines, such as TNF-α. This pro-inflam-
matory protein leads to an increased inflammatory level 
-also called a chronic low-grade inflammation- which 
seems to be strictly associated with obesity and insulin 
signaling impairment [16–18].
Notably, TLR4 is associated with TRB3 synthesis 
through the development of the ER stress [19]. The ER 
dysfunction arises as a consequence of TLR4 activation 
and can be modulated by anti-inflammatory cytokines 
[20]. Yao et  al. observed that the activation of TLR4 by 
modified low-density lipoproteins is essential to induce 
ER stress in the macrophages [21]. Pierre et al. [22] dem-
onstrated a strong relationship between TLR4 and ER 
stress; the authors showed that knockout mice for TLR-4 
in the liver, fat, and muscle tissues and that were fed a 
high fat diet did not develop ER stress. TLR4/2 activation 
in the macrophages activates IRE1/XBP1s and contrib-
utes to proinflammatory cytokine production. Moreover, 
Koh and colleagues [23] reported that high fat diet, obe-
sity, and T2DM induce stress reticulum and in response 
to this condition, TRB3 levels increase in muscle cells. 
Based on these findings, the authors hypothesized that 
impairments in insulin signaling could result from the 
increase in TRB3 levels. To confirm this hypothesis, the 
authors first overexpressed TRB3 and observed impair-
ments in insulin signaling; on the other hand, when the 
transcription of TRB3 was silenced, the reverse phenom-
enon was observed in insulin signaling such as improved 
insulin sensitivity and glucose uptake. Further, when the 
authors induced animals to the ER stress, they observed 
an increase in TRB3 transcription levels concomitant 
with the losses in insulin signaling [23].
ER stress has been linked to insulin resistance in mul-
tiple tissues and is the major site in the cell for lipid and 
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protein synthesis, folding, assembly, and trafficking, as 
well as cellular Ca2+ storage [24]. Another way how ER 
stress can induce the increase of TRB3 is through the 
increase of calcium in the cytosol. Obese people have 
higher calcium concentration in the cell due to the lipid-
induced de-activation of the calcium pump [25] and to 
the opening of the IP3R ER calcium-channel. This is due 
to the activation of the glucagon receptor that is triggered 
by 2 processes: 1- The formation of IP3 by phospholi-
pase C [26] and 2- The direct activation of the channel 
by PKA-mediated phosphorylation of IP3R [27]. This ele-
vated calcium concentration will activate CaMKII, which 
will decrease p58IPK, induce ER stress, and activate PERK 
and ATF-4 pathways; this activation will in turn increase 
the synthesis of TRB3 [4].
In this regard, the TRB3 (a mammalian homolog of 
Drosophila tribbles) emerges as a negative regulator of 
the insulin signaling in several tissues, including the 
liver. Du et al. [28] found that in obese mice, there was an 
overexpression of the TRB3 protein that can be associ-
ated with a distal protein from the insulin pathway–the 
protein kinase B (Akt)– and can hence hinder Akt phos-
phorylation and its subsequent activation. Consequently, 
there was a reduction in insulin signaling on the insulin-
sensitive tissues as well as other tissues such as the liver, 
triggering uncontrolled hepatic glucose production [28]. 
On the other hand, TRB3 inhibition reduces insulin 
resistance that is associated with obesity and helps con-
trol blood glucose levels [29].
Insulin resistance state: the role of TRB3 
in suppressing Akt activity
TRB3 is part of a new family of proteins and consists 
of three members (TRB1, TRB2 and TRB3), which are 
associated with numerous proteins including transcrip-
tion factors and protein kinases (as well as E3 ubiquitin 
ligase). By interacting with different factors, the TRBs 
regulate many biological processes, including cell growth, 
differentiation, and metabolism [28]. TRB1 interacts with 
the mitogen-activated protein kinase (MAPK) modulat-
ing its kinase activity, resulting in muscle cell prolifera-
tion [30, 31]. TRB2 interacts with transcription factors 
C/EBP and is implicated in adipocyte differentiation [32]. 
TRB3 isoform, which has been the focus of several stud-
ies, emerges as a key player in in the regulation of insulin 
signaling through inhibition of Akt activity [28, 33, 34]. 
The effects of TRB3 in the organism remain unclear; for 
instance, TRB3 can have positive effects in the adipocytes 
because it can increase fatty acid oxidation [35]; con-
versely, TRB3—induced by ER stress—can have negative 
effects in the liver because it can decrease insulin signal-
ing by binding to Akt and inhibiting it [36].
The role of TRB3 on Akt activity has been studied in 
different animal tissues. The amounts of TRB3 RNA 
and protein were increased in livers of db/db diabetic 
mice as compared to those in wild-type mice [28]. In 
both the skeletal muscle and the liver, TRB3 has been 
proposed to be a suppressor of Akt activity, mainly dur-
ing fasting period and/or diabetic state [28, 37, 38]. The 
main role of hepatic TRB3 on Akt activity is to bind to 
Akt and then inhibit its phosphorylation at Thr308 and 
Ser473motifs, which are the critical motifs for Akt acti-
vation induced by growth factors and insulin [28]. Inter-
estingly, when TRB3 was knockdown in the liver, Akt 
became active and the serum glucose levels went back 
to normal [37]. Conversely, when TRB3 was overex-
pressed in the liver, it promoted hyperglycemia and glu-
cose intolerance [28],
Further, when TRB3 is overexpressed in the liver it pro-
moted hyperglycemia and glucose intolerance, the same 
frame was showed in db/db mice that have high con-
centration of TRB3 in the liver [28]. Some authors have 
suggested that, by interfering with Akt activation, TRB3 
contributes to insulin resistance in individuals with sus-
ceptibility to type 2 diabetes. Recently, Yu and colleagues 
[39] suggested that liver transcription of TRB3 levels may 
also be regulated by phosphoserine aminotransferase 1 
(PSAT1), an enzyme that acts on the synthesis of the pro-
tein serine. The authors showed that PSAT1 inhibited the 
transcription of TRB3 in the liver and these results were 
accompanied by an increased activity of Akt and conse-
quently a higher sensitivity to insulin and glucose uptake. 
Moreover, human polymorphism of TRB3 (Q84R) leads 
to an important inhibition of Akt activity and is related 
to the development of insulin resistance and an increased 
risk of cardiovascular disease [40].
In the liver, the expression of TRB3 is induced during 
fasting period in order to reduce insulin signaling at a 
time when the nutrient supply is not abundant, prevent-
ing the organism to reach a state of hypoglycemia [28, 
33, 34]. After a meal, when the circulating insulin levels 
are increased, there is a 50  % reduction in the expres-
sion of TRB3 [38]. Elevated levels of TRB3 protein and 
the increased association of TRB3 with Akt are related to 
insulin resistance and, consequently, obesity and diabetes 
development [28, 33, 38].
In the liver of patients with DM2, TRB3 expression is 
increased independent of nutrients’ excess or hyper-
insulinemia, leading to defects in insulin signaling and 
triggering a reduction in glycogen synthesis that is 
mediated by insulin as well as an increase in gluconeo-
genesis, which leads to hyperglycemia [28, 33, 34]. The 
negative effects of TRB3 block the activities stimulated 
by insulin, such as the inhibitory effect on hepatic glucose 
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production and the inactivation of transcription factors 
for gluconeogenic enzymes (such as Foxo1 and PGC-1α) 
[28, 38].
Studies in obesity-animal models (either induced by a 
high fat diet or genetically modified) showed an increase 
in TRB3 expression and in the TRB3/Akt association in 
the skeletal muscle tissue and the liver, with a consequent 
increase in blood glucose concentration, which later on 
led to the development of insulin resistance and DM2 
[28, 29, 41].
On the other hand, the inhibition of TRB3 activity 
increases the phosphorylation of Akt in response to insu-
lin in the liver [28, 38]. Previous studies have shown that 
the absence of TRB3 is related to increased insulin sensi-
tivity [28, 33]. Studies developed by our group, seeking to 
investigate the acute effect of physical exercise, showed a 
reduction in the expression of TRB3 protein in the skel-
etal muscle and liver of exercised animals [29, 41]. This 
phenomenon was associated with increased insulin sen-
sitivity in animals induced to obesity by a high fat diet 
[29, 41]. These findings shed light on the importance of 
investigating the effect of, not only an acute period of 
exercise, but also physical training (chronic exercise) on 
TRB3 protein and its role in restoring insulin sensitivity 
in the liver tissue. Despite the need to define many other 
effects of physical exercise on intracellular signaling 
pathways, all these findings open new perspectives for 
understanding the effect of physical exercise on glycemic 
control and glucose production in the liver.
The effect of exercise in the regulation of hepatic 
glucose production and the inhibitory effect 
of physical exercise on TRB3
Despite the beneficial effects of exercise on skeletal mus-
cle and the increase in insulin sensitivity in animals and 
obese/diabetic patients, there is a lack of studies that 
demonstrate the role of physical exercise in regulating 
the insulin signaling pathway and the hepatic glucose 
production in the liver in these conditions.
In this regard, our research laboratory has sought to 
identify the effects of physical exercise on the liver tis-
sue of obese and diabetic animals [29, 42–44]. The results 
have allowed a better understanding of the role of physi-
cal exercise in regulating some key proteins involved in 
glycogenolysis and gluconeogenesis in the liver.
A study that used a single session of aerobic exercise 
showed that exercise can decrease fasting hyperglyce-
mia in obese mice induced by a high fat diet [42]. This 
effect on blood glucose was associated with a decrease in 
the association of Foxo1/PGC-1α inside the hepatocytes’ 
nucleus, consequently, it lowered the expression of the 
gluconeogenic enzymes PEPCK and G6Pase. There was 
also a reduction in hepatic glucose production, typically 
exaggerated under the condition of obesity and insulin 
resistance [42].
In the same direction, De Souza et  al. [43] observed 
that a single session of physical exercise was able to 
decrease the expression of the nuclear factors Foxo1 
and HNF-4α, both in genetically modified mice (ob/ob) 
and in Swiss obese mice induced by a high fat diet [43]. 
This cellular behavior was followed by a lower transcrip-
tion of the gluconeogenic enzymes PEPCK and G6Pase 
and, consequently, a decrease in fasting glycemia in 
these two types of mice. Further, the obese animals sub-
jected to physical exercise protocol had higher preser-
vation and synthesis of hepatic glycogen [43]. Another 
study by Hoene et al. showed that after a single session 
of treadmill running, there was a rapid and pronounced 
increase of enzymes and transcription factors that reg-
ulated the hepatic metabolism such as G6Pase, pyru-
vate dehydrogenase kinase 4 (PDK4), IRS-2, PGC1- α, 
AMPK and Akt, which reinforces the idea that physical 
exercise might play a major role in TRB-3 activity [45].
To better understand the positive effect of physical 
exercise on insulin signaling in the liver of obese ani-
mals, Lima et al. investigated the effect of a single session 
of physical exercise on TRB3 protein levels and TRB3 
association with Akt protein [29]. It was verified that the 
physical exercise reduced the expression of TRB3 and 
TRB3/Akt association. Consequently, such phenomenon 
was accompanied by an increase in Akt activity and its 
phosphorylation, leading to the inactivation of Foxo1. 
Associated with these adaptations, there was a reduction 
in the expression of the gluconeogenic enzyme PEPCK, 
both in ob/ob mice and in obese Swiss mice induced by 
a high fat diet [29]. Although these studies have dem-
onstrated a significant effect of physical exercise on the 
TRB3 protein, they did not explain how this phenome-
non happened.
To answer these questions, a study conducted by our 
research group described a new mechanism by which 
physical exercise could increase insulin signaling in the 
liver tissue while preserving Akt activity [44]. Aerobic 
physical training was able to increase the expression of 
endosomal adaptor protein expression (APPL1). This 
protein had the ability to inhibit the interaction between 
Akt and TRB3 in mice hepatocytes, which was accompa-
nied by an increase in Akt activation in response to insu-
lin stimulation [44].
Previous studies performed by Cheng et  al. and 
Schenck et  al. demonstrated that APPL1 regulated the 
activity of Akt [9, 46]. Both experiments with isolated 
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cells, such as tissue analysis, showed that APPL1 com-
peted directly with TRB3 in order to bind to Akt. Fur-
thermore, overexpression of APPL1 could neutralize the 
inhibitory effect of TRB3 in the activation of Akt when 
stimulated by insulin and suppress the gluconeogenic 
program in the hepatocytes of obese mice [9].
Marinho et al. observed that aerobic training was able 
to increase the expression of APPl1 and Akt and the 
association between APPL1 and Akt protein in obese 
mice induced by a high fat diet. These results were con-
firmed by immunohistochemistry experiment, in which 
the obese mice submitted to physical training protocol 
showed higher levels of APPL1 in hepatic cells when com-
pared to their sedentary pairs. Therefore, the increased 
expression of APPL1 resulted in an increased activation 
of Akt [44]. Moreover, it was also observed that physical 
training increased Foxo1 phosphorylation and decreased 
PGC-1α expression, reducing the association of these 2 
proteins and consequently, the gluconeogenic program, 
by reducing the expression of PEPCK and G6Pase .
In addition to this phenomenon, physical training 
increased the hepatic glycogen content due to increased 
phosphorylation of glycogen synthase enzyme kinase 3 
(GSK3), leading to dephosphorylation and activation of 
glycogen syntheses (GS) [44]. In the skeletal muscle and 
the liver, insulin can stimulate the accumulation of gly-
cogen by increasing its synthesis. This effect is obtained 
by dephosphorylation of the glycogen synthase enzyme 
(GS), where such dephosphorylation is only possible 
from the inhibition of GSK3. Under insulin stimula-
tion, Akt phosphorylates GSK3 and inactivates it, which 
reduces the rate of GS phosphorylation, thus, increasing 
its activity. Therefore, in the presence of insulin, glucose 
may be stored as glycogen [44]. The potential mecha-
nism of inhibition of gluconeogenesis by physical training 
through increasing APPL1 and inhibiting TRB3 is sum-
marized in Figs. 1, 2.
Conclusion
In summary, it can be concluded that physical exercise 
is an effective treatment to improve insulin sensitivity 
and contribute to glycemic control. Moreover, its effects 
go beyond the skeletal muscle, with specific adaptations 
on molecular pathways involved in hepatic gluconeo-
genesis regulation. Although future studies are needed 
to elucidate the effects of physical exercise on the liver, 
it seems clear that, when performed regularly, it can play 
an important role in preventing the development of insu-
lin resistance and diabetes through the APPL1/TRB3/
Akt pathway. Among the pronounced effects achieved 
by physical training, the inhibition of TRB3 in the liver 
could be highlighted, which leads to a decrease in glu-
coneogenesis in obese and diabetic animals. It is note-
worthy that many of the observed effects were obtained 
Fig. 1 The increased expression of TRB3, induced by obesity or by the condition of insulin resistance, promotes a decrease in the phosphoryla-
tion of Akt and Foxo1, which enables the translocation of Foxo1 from the cytoplasm to the nucleus. Activated in the nucleus, the Foxo1 increases 
PGC-1α transcription and its association with this protein, starting the gluconeogenic program. As a consequence, there is an increase in the tran-
scription of gluconeogenic enzymes, such as PEPCK and G6Pase in the liver resulting in hepatic glucose production
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independent of changes in body composition; this rein-
forces the importance of maintaining a physically active 
lifestyle to prevent insulin resistance and DM2.
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